RUA Life Sciences plc

25.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:RUAHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 2.74%
Div yield —
ROE —
Medical Devices
Beta (5Y) 0.98
PE TTM 56.19
TSR TTM 112.50%
Mkt cap £15.83M
ROIC 2.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
30p
17.92%
(54.63%)
Hold 1|12|7|9|3
1Q26
2Q26
3Q26
4Q26
Earnings per share£
0.33
0.32
0.33
0.34
2.23%
(9.61%)
(3.12%)
5.02%
Revenue£M
0.703
0.711
0.705
0.738
2.43%
2.22%
2.90%
9.33%
Peers (US$21.38M)
Cap (US$)
PE
21.47M
—
Capital
TTM
5Y
10Y
Leveragex
0.777
—
—
EBIT/Intx
0.757
0.288
0.322
Own earn%
(90.96)
75.92
72.47
Sh yield%
38.13
22.83
29.08
Owners
Insiders/Inst%
6.65
41.78
Short interest%
0.61
SBC / revenue%
4.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
15–24
$1 testx
0.0
Incr. ROIC%
4